市场调查报告书
商品编码
1442909
角膜植入物 - 全球市场考量、竞争格局、市场预测 (2030)Corneal Implant - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
预计2024-2030年预测期内,全球角膜植入物市场规模将以6.43%的复合年增长率大幅成长。对角膜植入物的需求主要是由角膜失明、眼外伤和高眼压(青光眼)病例数量的增加所推动的。此外,预计2024-2030年预测期内,各行业参与者在角膜植入物开发方面的合作活动不断增加以及角膜捐赠者的稀缺将有助于市场的整体成长。
角膜植入物市场动态
根据BrightFocus Foundation(2022)提供的数据,全球有 8,000 万人患有青光眼,预计到 2040 年这一数字将增加到 1.11 亿以上。根据同一消息来源,失明或低视力影响着 330 万 40 岁以上的美国人。此外,世界卫生组织(WHO)发布的最新研究数据得出结论,角膜失明是继青光眼和白内障之后的第三大失明原因,影响全球约1000万人。
因此,青光眼、角膜失明等眼科疾病的盛行率不断增加,产生了对角膜植入物的需求,从而导致角膜植入物市场的积极增长。
角膜捐赠者数量有限也是角膜植入市场的驱动因素之一。例如,根据American Academy of Ophthalmology(2021)的数据,大约有 1,000 万人需要角膜移植,因此世界各地对角膜捐赠者的需求很高。因此,角膜捐赠者的数量少或稀缺在推动角膜植入市场方面发挥着至关重要的作用。
然而,人造角膜的排斥和与设备相关的高成本是可能限制角膜植入物市场成长的市场障碍。
角膜植入物市场细分分析
在角膜植入市场的手术领域,全层角膜移植类别预计将在 2023 年获得可观的收入占有率。这可能是由于全层角膜移植术提供的各种优点。
全层角膜移植术,也称为角膜移植,涉及透过手术切除角膜的疾病或受损区域,然后用健康组织取代它。这项手术可以帮助缓解疼痛、改善视力并治疗严重感染或角膜区域损伤。
根据Eye Bank Association of America(2022)的数据,2021 年美国用于全层角膜移植的循环组织总数为 79,641 份。上述数字清楚地显示了对全层角膜移植的需求和需求不断增长。
因此,由于上述因素,预计全层角膜植入物类别将显着成长,从而推动预测期内整体角膜植入物市场的成长。
预计北美将主导整个角膜植入市场
在所有地区中,预计到 2023 年,北美将在角膜植入物市场中占最大占有率。这可以归因于该地区主要市场参与者的存在。此外,有效的报销政策、与角膜植入物相关的研发活动的增加以及角膜失明负担的增加也促进了北美角膜植入物市场的成长。
根据美国疾病管制与预防中心(2022)发布的数据,估计2017年约有600万美国人视力丧失,100万美国人失明。此外,糖尿病和高血压等眼科疾病危险因子的盛行率不断增加,导致眼科疾病的盛行率增加,从而增加了对角膜植入物的需求。根据美国疾病管制与预防中心 (CDC, 2020) 的National Diabetics Statistics Report,2020 年约有 3,420 万美国人患有糖尿病。报告也指出,大约 8,800 万美国人患有糖尿病前期。因此,美国眼部疾病负担的增加导致角膜植入物市场的成长加快,进一步推动了北美角膜植入物市场的成长。
本报告提供了全球角膜植入物市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。
Corneal Implants Market By Procedure (Endothelial Keratoplasty, Penetrating Keratoplasty, And Others), Disease (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, And Others), End-User (Hospitals, Eye Clinics, And Ambulatory Surgical Centers) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of corneal blindness, eye injury, and other ophthalmic disorders and rising partnership activities for the development of corneal implants combined with increasing technological advancements in product design
The global Corneal Implants Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.43% during the forecast period from 2024 to 2030. The demand for corneal implants is primarily being boosted by the increasing cases of corneal blindness, eye injuries, ocular hypertension (glaucoma), and among others. Additionally, the rising partnership activities among various industry players for the development of corneal implants and the scarce number of cornea donors are expected to contribute to the overall growth of the corneal implants market during the forecast period from 2024-2030.
Corneal Implants Market Dynamics:
According to data provided by BrightFocus Foundation 2022, globally 80 million people are suffering from glaucoma and this number is expected to increase to over 111 million by the year 2040. As per the same source, blindness or low vision affects 3.3 million Americans after the age of 40 years. Additionally, as per the data published by the World Health Organization (WHO) in the latest study, it was concluded that corneal blindness is the third-leading cause of blindness after glaucoma and cataracts affecting around 10 million people globally.
Thus the rising prevalence of ophthalmic disorders such as glaucoma, corneal blindness, and other disorders, will create a need for corneal implants, thus resulting in the positive growth of the Corneal Implants market.
The presence of only a minimal number of corneal donors is another driver for the Corneal Implants market. For instance, according to the American Academy of Ophthalmology 2021, there is a high demand for corneal donors around the world as nearly 10 million people need corneal transplants. Thus, the presence of a low or scarce number of cornea donors will play a pivotal role in driving the Corneal Implants Market.
However, the rejection of artificial corneas and, the high costs associated with the device, are some of the market barriers that may restrict the growth of the corneal implants market.
Corneal Implants Market Segment Analysis:
Corneal Implants Market by Procedure (Endothelial Kertoplasty, Penetrating Keratoplasty, and Others), Disease (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, and Others), End-User (Hospitals, Eye Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the procedure segment of the Corneal Implants market, the Penetrating Keratoplasty category is expected to amass a significant revenue share in the year 2023. This can be attributed to the various advantages provided by the penetrating keratoplasty procedures.
Penetrating Keratoplasty also known as corneal transplant or corneal graft is the surgical removal of diseased or damaged portion of the cornea, which is followed by implantation of healthy tissue. The procedure helps to relieve pain, improve sight, and treat severe infection or damage in the corneal region.
According to the Eye Bank Association of America 2022, the total number of U.S.-supplied tissue distributed for penetrating keratoplasty was 79,641 in 2021. The above-mentioned figure highlights the rising demand and the need for penetrating keratoplasty procedures.
Therefore, owing to the above-mentioned factors, the penetrating keratoplasty category is expected to register significant growth, thereby driving the growth of the overall Corneal Implants market during the forecast period.
North America is expected to dominate the overall Corneal Implants Market:
Among all the regions, North America is estimated to account for the largest share of the Corneal Implants market in the year 2023. This can be attributed to the presence of major market players in the region. Additionally, efficient reimbursement policies, increasing R&D activities related to corneal implants, and increasing burden of corneal blindness are some of the contributing factors to the growth of the Corneal Implants market in North America.
According to the data published by the Centers of Disease Control and Prevention 2022, it was estimated that approximately 6 million Americans had vision loss and 1 million Americans was suffering from blindness in 2017. Additionally, increasing the prevalence of risk factors of ophthalmic disorders such as diabetes and hypertension in turn will increase the prevalence of ophthalmic disorders and ultimately increase the demand for corneal implants. As per the National Diabetics Statistics Report by the Centers for Disease Control and Prevention (CDC, 2020), about 34.2 million Americans had diabetes in 2020. The report further stated that approximately 88 million Americans showed pre-diabetes levels. Thus, the increasing burden of ocular disorders in the United States will eventually lead to an increase in the growth of the corneal implants market, which will further propel the market for corneal implants market in North America.
Moreover, the occurrence of various product development and partnership activities in the region is another driving factor for the corneal implants market. For Instance, in July 2022 Carl Zeiss Meditec and Precise Bio announced an agreement for the development and commercialization of tissue-based implants.
Thus, the factors mentioned above, are thereby responsible for driving the Corneal Implants market in the United States, which will further boost the market for Corneal Implants in North America during the forecast period.
Corneal Implants Market Key Players:
Some of the key market players operating in the Corneal Implants Market include EyeYon, AJL Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight Network, Corneat Vision, DIOPTEX, among others.
Recent Developmental Activities in the Corneal Implants Market:
Key Takeaways from the Corneal Implants Market Report Study
Target Audience who can be benefited from this Corneal Implants Market Report Study
Frequently Asked Questions for the Corneal Implants Market:
Corneal Implants are artificial corneas usually used to replace the diseased cornea of the eye via endothelial keratoplasty, penetrating keratoplasty, and other ophthalmic procedures. It is mostly used to treat ocular conditions such as corneal ulcers, corneal blindness and Fuchs Dystrophy.
The global Corneal Implants Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.43% during the forecast period from 2024 to 2030.
The Corneal Implants Market is slated to witness prosperity owing to factors such as the growing incidence of corneal blindness, eye injury, and other ophthalmic procedures. Additionally, scare number of cornea donors and rising number of partnerships for the development of corneal implants, are some of the factors which can result in appreciable revenue growth in the Corneal Implants Market during the forecast period (2024-2030).
Some of the key market players operating in the Corneal Implants Market include EyeYon, AJL Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight Network, Corneat Vision, DIOPTEX, among others.
North America is expected to dominate the overall Corneal Implants Market during the forecast period, 2024 to 2030. This can be attributed to the presence of major players in the region, efficient reimbursement policies, increasing R&D activities related to corneal implants, increasing burden of corneal blindness, and rising elderly population prone to ophthalmic diseases are some of the factors influencing the positive growth of the market in the region during the forecast period.